AVEO / AVEO Pharmaceuticals, Inc. (AVEO) CEO Michael Bailey on Q2 2022 Results - Earnings Call Transcript

Here is how AVEO Pharmaceuticals (AVEO) and Merit Medical (MMSI) have performed compared to their sector so far this year. more_horizontal

AVEO Oncology (AVEO) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well. more_horizontal

AVEO (AVEO) delivered earnings and revenue surprises of 43.75% and 1.67%, respectively, for the quarter ended September 2022. Do the numbers hold clue more_horizontal

BOSTON, Aug. 31, 2022 (GLOBE NEWSWIRE) -- AVEO Oncology (Nasdaq: AVEO), a commercial stage, oncology-focused biopharmaceutical company committed to de more_horizontal

Does AVEO Pharmaceuticals (AVEO) have what it takes to be a top stock pick for momentum investors? Let's find out. more_horizontal

AVEO (AVEO) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are more_horizontal

AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO ) Q2 2022 Earnings Conference Call August 4, 2022 4:30 PM ET Company Participants Hans Vitzthum - LifeSci Advi more_horizontal

AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO ) Q1 2022 Earnings Conference Call May 5, 2022 8:00 AM ET Company Participants Hans Vitzthum – LifeSci Advis more_horizontal